Predictive Accuracy of a Clinical Model for Carriage of Pathogenic/Likely Pathogenic Variants in Patients with Dementia and a Positive Family History at PUMCH
<b>Background and Objectives:</b> Identifying carriers of Pathogenic/Likely Pathogenic Variants in patients with dementia is crucial for risk stratification, particularly in individuals with a family history. This study developed and validated a clinical prediction model using whole-exome sequencing-confirmed cohorts. <b>Methods:</b> A total of 601 Chinese patients with dementia and a family history were enrolled at Peking Union Medical College Hospital, with 476 in a retrospective derivation cohort and 125 in a temporal validation cohort. Predictive factors included age at onset, <i>APOE</i> ε4 status, and family history characteristics. Model performance was assessed using discrimination and calibration metrics. <b>Results:</b> In the derivation cohort (median age at onset 66 years), 10.3% carried Pathogenic/Likely Pathogenic Variants. Among patients with dementia, those with age at onset < 55 years (OR 2.56, <i>p</i> = 0.0098), more than two affected relatives (OR 3.32, <i>p</i> = 0.0039), parental disease history (OR 4.72, <i>p</i> = 0.015), and early-onset cases in the family (OR 2.61, <i>p</i> = 0.0096) were positively associated with Pathogenic/Likely Pathogenic Variant carriage, whereas <i>APOE</i> ε4 carriage was inversely associated (OR 0.36, <i>p</i> = 0.0041). The model achieved an area under the curve of 0.776 (95% CI, 0.701-0.853) in the derivation cohort and 0.781 (95% CI, 0.647-0.914) in the validation cohort (median age at onset 58 years), with adequate calibration. <b>Conclusions:</b> This model demonstrated strong predictive performance for Pathogenic/Likely Pathogenic Variant carriage, supporting its clinical utility in guiding genetic testing. Further research is needed to refine the model.
Authors
- Liling Dong (ORCID: https://orcid.org/0000-0002-6331-8935)
- Li Shang (ORCID: https://orcid.org/0009-0006-4062-1065)
- Yixuan Huang (ORCID: https://orcid.org/0000-0003-1679-8435)
- Meiqi Wu (ORCID: https://orcid.org/0000-0001-7305-6302)
- Yun‐Fan You
- Longze Sha (ORCID: https://orcid.org/0000-0001-7372-6644)
- Li Huo (ORCID: https://orcid.org/0000-0003-1216-083X)
- Shanshan Chu (ORCID: https://orcid.org/0000-0003-2979-9234)
- Jialu Bao (ORCID: https://orcid.org/0000-0001-9407-3339)
- Yifei Wang (ORCID: https://orcid.org/0000-0003-0956-2459)
- Bo Li (ORCID: https://orcid.org/0000-0003-0022-0583)
- Wenjun Wang (ORCID: https://orcid.org/0000-0002-2384-6653)
- Tianyi Wang (ORCID: https://orcid.org/0009-0009-9452-3956)
- Yafei Li (ORCID: https://orcid.org/0000-0003-1158-7671)
- Feng Feng (ORCID: https://orcid.org/0000-0002-3507-1154)
- Wei Jin (ORCID: https://orcid.org/0000-0001-8040-8126)
- Ling Qiu
- Qi Xu (ORCID: https://orcid.org/0000-0003-2660-8092)
- Yuhan Jiang (ORCID: https://orcid.org/0009-0001-1098-0722)
- Yahui Qiu
- Yutong Zou (ORCID: https://orcid.org/0000-0001-5750-5286)
- Chenhui Mao
- Jing Gao (ORCID: https://orcid.org/0000-0002-2131-7301)
- Bo Hou (ORCID: https://orcid.org/0000-0003-0520-3969)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- Biomedicines
- Published
- 2025-05-19
- DOI
- https://doi.org/10.3390/biomedicines13051235
- Citations
- 1
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- Peking Union Medical College Hospital
- Peking Union Medical College
- National Key Research and Development Program of China